The BOB.1/OBF.1 co-activator is essential for octamer-dependent transcription in B cells

European Journal of Immunology

Volumn 30, Issue 2, 2000, Pages 458-469

  Laumen, Helmut ^a   Nielsen, Peter J ^b   Wirth, Thomas ^a,c  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

^c UNIVERSITY OF ULM   (Germany)

Author keywords

B cell specific gene expression; BOB.1 OBF.1 co activator; Conditional gene regulation; Oct1 Oct2 transcription factor; Octamer dependent transcription

Indexed keywords

CELL PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; GENETIC TRANSCRIPTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; TRANSGENIC MOUSE;

ANIMALS; B-LYMPHOCYTES; GENE EXPRESSION REGULATION; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC;

EID: 0033963959     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200002)30:2<458::AID-IMMU458>3.0.CO;2-5     Document Type: Article

References (58)

1. Staudt, L. M. and Lenardo, M. J., Immunoglobulin gene transcription. Annu. Rev. Immunol. 1991. 9: 373-398.
2. Libermann, T. A. and Baltimore, D., Transcriptional regulation of immunoglobulin gene expression. In Cohen, P. and Foulkes, J. G. (Eds.) The hormonal control of gene transcription. Elsevier-Biomedical. Amsterdam 1991, pp 385-407.
3. Schaffner, W., How do different transcription factors binding the same DNA sequence sort out their jobs? Trends Genet. 1989. 5: 37-39.
4. Verrijzer, C. P. and Van der Vliet, P. C., POU domain transcription factors. Biochim. Biophys. Acta 1993. 1173: 1-21.
5. Schöler, H. R., Octamania: The POU factors in murine development. Trends Genet. 1991. 7: 323-329.
6. Zwilling, S., Annweiler, A. and Wirth, T., The POU domains of the Oct1 and Oct2 transcription factors mediate specific interaction with TBP. Nucleic Acids Res. 1994. 22: 1655-1662.
7. Zwilling, S., König, H. and Wirth, T., HMG2 functionally interacts with the POU domains of octamer transcription factors. EMBO J. 1995. 14: 1198-1208.
8. Pierani, A., Heguy, A., Fujii, H. and Roeder, R. G., Activation of octamer-containing promoters by either octamer-binding transcription factor 1 (OTF-1) or OTF-2 and requirement of an additional B-cell-specific component for optimal transcription of immunoglobulin promoters. Mol. Cell. Biol. 1990. 10: 6204-6215.
9. Luo, Y., Fujii, H., Gerster, T. and Roeder, R. G., A novel B cell-derived coactivator potentiates the activation of immunoglobulin by octamer-binding transcription factors. Cell 1992. 71: 231-241.
10. Wirth, T., Pfisterer, P., Annweiler, A., Zwilling, S. and König, H., Molecular principles of Oct2-mediated gene activation in B cells. Immunobiology 1995. 193: 161-170.
11. Pfisterer, P., Annweiler, A., Ullmer, C., Corcoran, L. and Wirth, T., Differential transactivation potential of Oct1 and Oct2 is determined by additional B cell-specific activities. EMBO J. 1994. 13: 1654-1663.
12. Annweiler, A., Müller-Immerglück, M. and Wirth, T., Oct2 transactivation from a remote enhancer position requires a B-cell-restricted activity. Mol. Cell. Biol. 1992. 12: 3107-3116.
13. Gstaiger, M., Knoepfel, L., Georgiev, O., Schaffner, W. and Hovens, C. M., A B-cell coactivator of octamer-binding transcription factors. Nature 1995. 373: 360-362.
14. Strubin, M., Newell, J. W. and Matthias, P., OBF-1, a novel B cell-specific coactivator that stimulates immunoglobulin promoter activity through association with octamer proteins. Cell 1995. 80: 497-506.
15. Luo, Y. and Roeder, R. G., Cloning, functional characterization, and mechanism of action of the B-cell-specific transcriptional coactivator OCA-B. Mol. Cell. Biol. 1995. 15: 4115-4124.
16. Pfisterer, P., Zwilling, S., Hess, J. and Wirth, T., Functional characterization of the murine homolog of the B-cell-specific coactivator BOB.1/OBF.1. J. Biol. Chem. 1995. 270: 29870-29880.
17. Shah, P. C., Bertolino, E. and Singh, H., Using altered specificity Oct-1 and Oct-2 mutants to analyze the regulation of immunoglobulin gene transcription. EMBO J. 1997. 16: 7105-7117.
18. Gstaiger, M., Georgiev, O., van Leeuwen, H., van der Vliet, P. and Schaffner, W., The B cell coactivator Bob1 shows DNA sequence-dependent complex formation with the Oct-1/Oct-2 factors, leading to differential promoter activation. EMBO J. 1996. 15: 2781-2790.
19. Cepek, K. L., Chasman, D. I. and Sharp, P. A., Sequence-specific DNA binding of the B-cell-specific coactivator OCA-B. Genes Dev. 1996. 10: 2079-2088.
20. Babb, R., Cleary, M. A. and Herr, W., OCA-B is a functional analog of VP16 but targets a separate surface of the Oct-1 POU domain. Mol. Cell. Biol. 1997. 17: 7295-7305.
21. Sauter, P. and Matthias, P., Coactivator OBF-1 makes selective contacts with both the POU-specific domain and the POU homeodomain and acts as a molecular clamp on DNA. Mol. Cell. Biol. 1998. 18: 7397-7409.
22. Zwilling, S., Dieckmann, A., Pfisterer, P., Angel, P. and Wirth, T., Inducible expression and phosphorylation of coactivator BOB.1/OBF.1 in T cells. Science 1997. 277: 221-225.
23. Schubart, D. B., Sauter, P., Massa, S., Friedl, E. M., Schwarzenbach, H. and Matthias, P., Gene structure and characterization of the murine homologue of the B cell-specific transcriptional coactivator OBF-1. Nucleic Acids Res. 1996. 24: 1913-1920.
24. Luo, Y., Ge, H., Stevens, S., Xiao, H. and Roeder, R. G., Coactivation by OCA-B: definition of critical regions and synergism with general cofactors. Mol. Cell. Biol. 1998. 18: 3803-3810.
25. Reich, L., Sharir, H., Ber, R., Wirth, T., Bergman, Y. and Laskov, R., Coordinate suppression of myeloma-specific genes in myeloma x fibroblast somatic hybrids. Somat. Cell Mol. Genet. 1996. 22: 1-20.
26. Qin, X. F., Reichlin, A., Luo, Y., Roeder, R. G. and Nussenzweig, M. C., OCA-B integrates B cell antigen receptor-, CD40L- and IL 4-mediated signals for the germinal center pathway of B cell development. EMBO J. 1998. 17 5066-5075.
27. Schubart, D. B., Rolink, A., Kosco-Vilbois, M. H., Botteri, F. and Matthias, P., B-cell-specific coactivator OBF-1/OCA-B/ Bob1 required for immune response and germinal centre formation. Nature 1996. 383: 538-542.
28. Kim, U., Quin, F.-F., Gong, S., Stevens, S., Luo, Y., Nussenzweig, M. and Roeder, R. G., The B-cell-specific transcription coactivator OCA-B/OBF-1/Bob-1 is essential for normal production of immunoglobulin isotypes. Nature 1996. 383: 542-547.
29. Nielsen, P. J., Georgiev, O., Lorenz, B. and Schaffner, W., B lymphocytes are impaired in mice lacking the transcriptional coactivator Bob1/OCA-B/OBF1. Eur. J. Immunol. 1996. 26: 3214-3218.
30. Pelletier, M. R., Hatada, E. N., Scholz, G. and Scheidereit, C., Efficient transcription of an immunoglobulin kappa promoter requires specific sequence elements overlapping with and down-stream of the transcriptional start site. Nucleic Acids Res. 1997. 25: 3995-4003.
31. Miller, C. L., Feldhaus, A. L, Rooney, J. W., Rhodes, L. D., Sibley, C. H. and Singh, H., Regulation and a possible stage-specific function of Oct-2 during pre-B-cell differentiation. Mol. Cell. Biol. 1991. 11: 4885-4894.
32. Falkner, F. G. and Zachau, H. G., Correct transcription of an immunoglobulin n gene requires an upstream fragment containing conserved sequence elements. Nature 1984. 310: 71-74.
33. Bergman, Y., Rice, D., Grosschedl, R. and Baltimore, D., Two regulatory elements for immunoglobulin n light chain gene expression. Proc. Natl. Acad. Sci. USA 1984. 81: 7041-7045.
34. Wirth, T., Staudt, L. and Baltimore, A., An octamer oligonucleotide upstream of a TATA motif is sufficient for lymphoid-specific promoter activity. Nature 1987. 329: 174-178.
35. Lenardo, M., Pierce, J. W. and Baltimore, D., Protein-binding sites in Ig gene enhancers determine transcriptional acitivity and inducibility. Science 1987. 236: 1573-1577.
36. Jenuwein, T. and Grosschedl, R., Complex pattern of immunoglobulin μ gene expression in normal and transgenic mice: non-overlapping regulatory sequences govern distinct tissue specificities. Genes Dev. 1991. 5: 932-943.
37. Annweiler, A., Müller, U. and Wirth, T., Functional analysis of defined mutations in the immunoglobulin heavy-chain enhancer in transgenic mice. Nucleic Acids Res. 1992. 20: 1503-1509.
38. Annweiler, A., Zwilling, S. and Wirth, T., Functional differences between the Oct2 transactivation domains determine the trans-activation potential of individual Oct2 isoforms. Nucleic Acids Res. 1994. 22: 4250-4258.
39. Ullman, K. S., Flanagan, W. M., Edwards, C. A. and Crabtree, G. R., Activation of early gene expression in T lymphocytes by Oct-1 and an inducible protein, OAP40. Science 1991. 254: 558-562.
40. Pfeuffer, I., Klein-Heßling, S., Heinfling, A., Chuvpilo, S., Escher, C., Brabletz, T., Hentsch, B., Schwarzenbach, H., Matthias, P. and Serfling, E., Octamer factors exert a dual effect on the IL-2 and IL-4 promoters. J. Immunol. 1994. 153: 5572-5585.
41. Chuvpilo, S., Schomberg, C., Gerwig, R., Heinfling, A., Reeves, R., Grummte, F. and Serfling, E., Multiple closely-linked NFAT/octamer and HMG I(Y) binding sites are part of the interleukin-4 promoter. Nucleic Acids Res. 1993. 21: 5694-5704.
42. Li-Weber, M., Salgame, P., Hu, C., Davydov, I. V., Laur, O., Klevens, S. and Krammer, P. H., Th2-specific protein/DNA interactions at the proximal Nuclear Factor-AT site contribute to the functional activity of the human IL-4 promoter. J. Immunol. 1998. 161: 1380-1389.
43. Duncliffe, K. N., Bert, A. G., Vadas, M. A. and Cockerill, P., A T cell-specific enhancer in the interleukin-3 locus is activated cooperatively by Oct and NFAT elements within a DNase I-hypersensitive site. Immunity 1997. 6: 175-185.
44. Ptashne, M. and Gann, A., Transcriptional activation by recruitment. Nature 1997. 386: 569-577.
45. Blackwood, E. M. and Kadonaga, J. T., Going the distance: a current view of enhancer action. Science 1998. 281: 61-63.
46. Gerster, T., Balmaceda, C.-G. and Roeder, R. G., The cell type-specific octamer transcription factor OTF-2 has two domains required for the activation of transcription. EMBO J. 1990. 9: 1635-1643.
47. Müller-Immerglück, M. M., Schaffner, W. and Matthias, P., Transcription factor Oct-2A contains functionally redundant activating domains and works selectively from a promoter but not from a remote enhancer position in non-lymphoid (HeLa) cells. EMBO J. 1990. 9: 1625-1634.
48. Feldhaus, A. L., Klug, C. A., Arvin, K. L. and Singh, H., Targeted disruption of the Oct-2 locus in a B cell provides genetic evidence for two distinct cell type-specific pathways of octamer element-mediated gene activation. EMBO J. 1993. 12: 2763-2772.
49. Littlewood, T. D., Hancock, D. C., Danielian, P. S., Parker, M. G. and Evan, G. I., A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res. 1995. 23: 1686-1690.
50. Bueler, H. and Mulligan, R. C., Induction of antigen-specific tumor immunity by genetic and cellular vaccines against MAGE: enhanced tumor protection by coexpression of granulocyte-macrophage colony-stimulating factor and B7-1. Mol. Med. 1996. 2: 545-555.
51. Morgenstern, J. P. and Land, H., Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 1990. 18: 3587-3596.
52. Grosschedl, R. and Baltimore, D., Cell-type specificity of immunoglobulin gene expression is regulated by at least three DNA sequence elements. Cell 1985. 41: 885-897.
53. Lernbecher, T., Müller, U. and Wirth, T., Distinct NF-nB/Rel transcription factors are responsible for tissue-specific and inducible gene activation. Nature 1993. 365: 767-770.
54. Wirth, T. and Baltimore, D., Nuclear factor NF-nB can interact functionally with its cognate binding site to provide lymphoid-specific promoter function. EMBO J. 1988. 7: 3109-3113.
55. König, H., Pfisterer, P., Corcoran, L. and Wirth, T., Identification of CD36 as the first gene dependent on the B cell differentiation factor Oct2. Genes Dev. 1995. 9: 1598-1607.
56. Wirth, T., Priess, A., Annweiler, A., Zwilling, S. and Oeler, B., Multiple Oct2 isoforms are generated by alternative splicing. Nucleic Acids Res. 1991. 19: 43-51.
57. Hahne, M., Wenger, R. H., Vestweber, D. and Nielsen, P. J., The heat-stable antigen can alter very late antigen 4-mediated adhesion. J. Exp. Med. 1994. 179: 1391-1395.
58. Kinsella, T. M. and Nolan, G. P., Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. Hum. Gene Ther. 1996. 7: 1405-1413.